Ecovacs Robotics

Phase A — Understand the business

Company Overview

What it is. Ecovacs Robotics (科沃斯) is the world's second-largest home service-robot maker and the original pioneer of the category — it shipped one of the first robot vacuums in China in 2009 and has been building floor-cleaning robots for a decade and a half. It began life in 1998 as TEK Electrical, an OEM contract manufacturer of traditional vacuum cleaners, and pivoted to branded robotics under the Ecovacs name. HQ is Suzhou, China; it IPO'd on the Shanghai Stock Exchange in 2018.

How it makes money — a two-brand consumer-hardware company. Revenue splits almost exactly 50/50 across two owned brands:

• Ecovacs brand — service robots (~50%). The DEEBOT robot vacuum/mop line is the core product and cash engine. Adjacent robots: WINBOT (window cleaners), GOAT (robotic lawn mowers, the fastest-growing new line), AIRBOT (air-purifier robots), DEEBOT Pro / Ecovacs Commercial (B2B floor scrubbers). FY2024 Ecovacs-brand revenue RMB 8.082B, +5.2% YoY.
• Tineco brand — smart home appliances (~50%). Premium cordless floor washers ("wet-dry" vacuums), stick vacuums, and personal-care (hair dryers). FY2024 Tineco revenue RMB 8.061B, +10.9% YoY — the faster grower of the two.
• OEM/ODM (residual, ~1.5%). Legacy contract manufacturing, RMB 258M, −34% YoY — deliberately being wound down. Combined Ecovacs+Tineco = 97.6% of revenue.

Business model. Vertically integrated: in-house R&D → proprietary design → own manufacturing (Suzhou + Shenzhen) → D2C omnichannel (own e-commerce, Amazon, Tmall/JD, plus offline retail — offline is a genuine Ecovacs strength vs. online-native rivals). Selling is direct-to-consumer at premium price points; there is no recurring/subscription revenue — this is a hardware replacement-cycle business, closer to Dyson or SharkNinja than to a SaaS robotics play.

Customers / suppliers / competitors. Customers = retail consumers globally (no customer concentration — a positive). Suppliers = the Yangtze/Pearl River Delta electronics supply base (motors, batteries, LiDAR, SoCs). Competitors = Roborock (the one that passed it), Dreame, Narwal, Xiaomi, and the collapsed iRobot. Contract structure: none — unit sales at retail, seasonal (Q4/Singles-Day heavy), FX-exposed (45% overseas).

Supply Chain

Map: upstream inputs → Ecovacs → end customer, named stakeholders.

• Upstream — components. Brushless motors, lithium cells, brushes/rollers, plastics, and the two differentiating inputs: (1) navigation sensors — dToF LiDAR, structured-light and RGB cameras for obstacle avoidance; (2) compute — application SoCs. Uniquely, Ecovacs makes several of these in-house through its component sub-brands: Kruisee Technology (high-precision dToF LiDAR — the KR S50 / KR S30 modules), TD Smart (lithium batteries), and TF Technology (plastics/injection-molded parts). This backward integration into LiDAR is a real, underappreciated moat vs. rivals who buy sensors.
• Compute partner — Rockchip. Ecovacs disclosed a collaboration with Rockchip (Rockchips Electronics) covering SoCs for cleaning robots and humanoid forms, "achieving rapid mass production". Rockchip is the named silicon chokepoint.
• Manufacturing — Ecovacs (own plants). Suzhou (HQ + primary) and Shenzhen. Vertically integrated: R&D sits next to the line, compressing NPI cost and inventory risk — the "China supply-chain cluster" advantage (Pearl River + Yangtze River Delta).
• Downstream — distribution. Own D2C e-commerce; marketplaces (Amazon, Tmall, JD.com); offline retail chains (China + increasingly Europe/US big-box); 9to5Toys/Best Buy-type promotional channels in the US.
• End customer. Global retail consumers; ~55% China, ~45% overseas (US, Germany, Nordics, Korea, SE Asia).

Chokepoints / single-source risks. (1) Advanced SoCs — the Rockchip dependency, and any China-facing US semiconductor export controls that reach into consumer-robot compute. (2) US tariffs — Ecovacs cut US prices up to 45% in April 2026 explicitly to "pass tariff savings" back, i.e. tariffs are a live cost/margin variable on ~its US business. (3) The LiDAR self-supply is a de-risker, not a chokepoint — a structural cost edge. This lens does not fail the "names or it didn't happen" test: Kruisee, TD Smart, TF Technology, Rockchip, Amazon, Tmall, JD are the named links.

Competitive Advantages (moats)

What's actually defensible:

1. Brand + 15-year head start + offline distribution. Ecovacs is the category's original name and still the #1 brand in China. Its offline retail presence is a genuine differentiator vs. online-native Dreame/Narwal — it reaches the older, higher-ticket buyer.
2. Vertical integration into LiDAR/batteries/plastics. Owning Kruisee (LiDAR), TD Smart (cells), TF (plastics) gives a BOM-cost and iteration-speed edge most rivals lack — they buy these modules. This is the most durable moat here.
3. Two-brand portfolio. Tineco (floor washers) diversifies away from the brutally competitive robot-vacuum core and is the faster grower — a real second leg.

What's NOT a moat (the uncomfortable truth):

• No switching costs, no network effect, no lock-in. Robot vacuums are a durable-goods replacement purchase every 3–5 years; the customer re-shops each cycle. The app ecosystem is not sticky enough to hold anyone.
• The technology moat is thin and copyable. The whole industry ships LiDAR nav + AI obstacle avoidance + self-empty/self-wash docks within one product cycle of each other. Dreame reached feature parity "two decades after Ecovacs" and now threatens to out-sell it. Ecovacs' CEO publicly raging about "copycats" (see Lens 9) is itself evidence the moat leaks.

Bargaining power. Over suppliers: moderate-to-good (own components + China cluster scale). Over customers: weak and deteriorating — this is a price-war category where the marginal buyer chooses on spec-per-yuan, and Ecovacs has repeatedly had to cut price and subsidize to hold share. Bargaining power over the customer is the crux of the bear case.

Segments

By brand (FY2024, the last fully broken-out year):

By geography (FY2024): overseas (Ecovacs+Tineco) RMB 6.808B, 42.2% of brand revenue, +12.6% YoY. By FY2025 overseas rose to RMB 8.8B, ~45% of total, +24.4%. Units: Ecovacs-brand service robots shipped 2.95M units in FY2024, +16.9% — note units grew 17% while brand revenue grew only 5%, i.e. ASPs fell ~10% — the price war showing up directly in the mix. FY2025 total revenue RMB 19.04B, +15.1%.

Trend read: Tineco (appliances) is accelerating and is the healthier segment; the Ecovacs-brand robot core is a unit-growth / price-decline machine — volume up, ASP down, revenue barely up. Overseas is the growth engine (from 42% → 45% of revenue) but it is also where the margin war is now "white-hot". our figures is empty — these are all, not; a hybrid refresh should populate the segment CSV from the annual report.

---

Phase B — Measure performance

Earnings Result

FY2025 (full year) — the headline "recovery":

• Revenue RMB 19.04B (~$2.8B), +15.1% YoY
• Net profit attributable RMB 1.76B (~$258M), +118% YoY
• Gross margin ~49.6%

The context that reframes the beat. The +118% profit jump is off a war-cratered base: FY2024 net was only RMB 806M (itself "less than half the 2021 peak" of ~RMB 2.0B), after net profit fell for two consecutive years and dropped ~60% in 2023. So FY2025 is a recovery toward a prior peak, not a new high — RMB 1.76B is roughly the 2021 level, reached four years later on nearly double the revenue. Margin recovery (GM 46.5% FY2024 → ~49.6%) + operating-expense discipline (total expense ratio 39.2% in 2024, down 3.9pts; sales expense ~30.3% of revenue) drove the profit rebound.

Q1 2026 — the warning sign: revenue RMB 4.9B (+27%) but net profit RMB 400M (−14.7%). Management cited FX headwinds, higher costs, and tough non-recurring-gain comps. Translation: the top line is still compounding but the "increasing revenue, not increasing profit" pattern that defined 2022–2024 re-appeared in the very first quarter after the recovery year. That is the single most important number in this lens.

Balance sheet / cash flow: strong operating cash flow in FY2025 ("surged over 17-fold" in the interim); but Q1 2026 cash flow declined alongside profit. Selling expense ~30% of revenue is the structural fact — a third of every yuan of revenue goes to marketing/sales, the cost of fighting the share war. Note the ~10% ASP decline (Lens 4) as an inventory/pricing-pressure flag.

Market reaction: the stock is down from a 52-week high of 111.69 to ~58.92 CNY (−47%) — the market has not rewarded the FY2025 profit recovery; it has de-rated the name toward the low end of its range, pricing the Q1'26 profit reversal and share loss over the reported rebound.

Earnings Calls (sentiment trend)

No transcripts on the shelf (transcripts/ empty) — this is a -derived sentiment read from management commentary and Chinese financial press. A hybrid refresh should ingest the Chinese earnings-call/interim summaries.

What management is focused on (trend across 2024→2026):

• 2024–early 2025 tone: confident, "value-for-money" pivot. Framing was "emerging from a high-investment phase," cost discipline, margin recovery, and international expansion as the growth story. Profit growth outpacing revenue = the proof point they leaned on.
• Aug 2025: combative. CEO Qian Cheng's product-launch "copycat" outburst (aimed at Dreame) — a defensive, us-vs-them tone that signals real competitive anxiety, not confidence. Management talking about lawsuits and imitation ≈ management worried about share.
• Q1 2026: defensive/explaining. Language shifted to explaining a profit miss — FX, costs, comps. The stopped-saying tell: the "margin recovery / operating leverage" narrative of 2024–25 went quiet the moment margins reversed.

Recurring phrases: "value-for-money," "international/overseas expansion," "premium," "innovation vs. imitation." Stopped saying: the clean "revenue up and profit up" story. Sentiment arc: confident → combative → defensive over four quarters — a deteriorating tone trend.

Comps

Home-cleaning-robot peer table.

Read: the striking line is Ecovacs at ~30x trailing / ~22x forward vs. Roborock at ~19x — the slower-growing, share-losing name trades at a premium multiple to the faster-growing one. Roborock grew revenue +56.5% in FY2025 vs. Ecovacs +15%, yet is cheaper on P/E. Bulls will say Ecovacs' forward P/E compresses to ~22x on the profit recovery; bears will say a ~30x trailing multiple on a share-loser in a price war is the whole problem. EV/EBIT for Ecovacs and 5y-avg ROE for both are not sourced — a hybrid refresh should compute these from the annual reports. iRobot's carcass (P/S 0.21x, bankrupt, sold to Picea) is the cautionary comp for what commoditization does to a category leader that stops innovating on cost.

Stock-Price Catalysts

Events that moved the tape (all ):

• 2021 peak → 2022–2023 collapse. The stock peaked in 2021 with net profit ~RMB 2B, then de-rated hard as profit fell two straight years (−60% in 2023) on price wars + inventory write-downs + overseas marketing burn. The single biggest multi-year move: earnings quality, not a one-off event.
• Aug 2024 — DEF CON hacking scandal. Security researchers demonstrated remote hijack of DEEBOT X2 cameras/mics; ~7,000 devices exposed; media coverage of vacuums "yelling slurs/chasing dogs" (see Lens 10) — a brand/trust event.
• FY2024 results (Mar 2025) — profit +31.7%, "recovery" narrative begins.
• Q1 2025 (Apr 2025) — net +59.4%, GM to 49.7% — the recovery accelerates; stock's better stretch.
• 2025 tariff overhang → Apr 2026 US price cuts (up to 45%) — tariff pass-through, a margin/volume swing factor on US sales.
• FY2025 results — profit +118% but stock still −47% off highs, and Q1 2026 profit −14.7% — the market reacted to the forward deterioration, not the trailing beat.

Pattern: the market reacts to profit trajectory and competitive share, not revenue. Revenue has compounded through the entire drawdown; the stock still halved. What moves this name is whether the price war is easing or intensifying (margin direction) and whether it's losing to Roborock/Dreame (share direction). Product launches (X11, GOAT mowers) barely move it. This is a "show me the margin" stock.

---

Phase C — Judge people & books

Management

• Track record. Founder Qian Dongqi (钱东奇) built Ecovacs from a 1998 vacuum OEM into the global #2 home-robot brand and a Shanghai-listed company — a genuine multi-decade operator; a Forbes-listed billionaire. Qian Cheng (钱程, b. 1990), his son, took over as CEO in 2019 after running e-commerce and international business from 2012 — the classic founder-to-heir handoff. On his watch the company doubled revenue but also went through the 2022–2024 profit collapse and the 2025 recovery.
• Tenure & skin in the game. Founder-controlled; the Qian family holds a substantial insider stake (exact % n/a from the shelf; a hybrid refresh should pull it from the annual report's top-10-holders table). This is a second-generation family-controlled company — high alignment, but also key-man/succession concentration.
• Capital allocation. Mixed. The 2022–2024 overseas-expansion + marketing splurge destroyed near-term returns ("increasing revenue but not increasing profit"), then the 2024–25 cost-discipline pivot restored them — ROE back to ~20.5%. Dividend is token (~0.5% yield, RMB 0.45/share) — this is a reinvest-for-growth story, not a capital-return one. The judgment: they over-invested into a price war, then course-corrected; whether they can hold the discipline (Q1'26 says maybe not) is the open question.
• Red flags (governance). The CEO's public "copycat" outburst and the dozens of mutual IP/non-compete lawsuits with Dreame read as competitive anxiety and a litigious posture. No related-party/accounting red flag surfaced in web search — but with no audited-filing shelf, governance diligence here is incomplete by construction.
• Archetype. Founder-controlled, second-generation professionalizing operator. Implies: long-term orientation and product focus (good), but also family concentration and an emotional, us-vs-them competitive stance (a risk in a war that rewards cold cost discipline).

Forensic Red Flags

Acting as a forensic analyst — but with a hard caveat: there is no audited financial shelf (filings=0, no CIK). Income-statement/balance-sheet forensics that require the 10-K/annual report cannot be performed here; they are n/a and flagged for the hybrid refresh. What the web does surface:

• Margin-of-safety on earnings quality. The ~10% ASP decline against 17% unit growth (Lens 4) and the recurring "revenue up, profit down" pattern (2022–24, and again Q1'26) mean reported profit is highly sensitive to price-war intensity and FX — low earnings quality/visibility. Non-recurring gains flattered a prior comp (management's own Q1'26 explanation) — watch for one-offs in the "recovery." All.
• Inventory write-downs were explicitly cited as a driver of the 2022–23 profit collapse — an inventory/demand-forecasting risk in a fast-cycle hardware business. Cannot verify current inventory days without the balance sheet — n/a.
• SBC / non-GAAP: n/a (no filing).

Regulatory findings (required sub-section). Read regulatory/regulatory-findings.md:

• SEC (EDGAR LR + AAER): none possible — Ecovacs has no CIK, is not an SEC registrant, so no EDGAR enforcement search applies. Zero SEC findings — but that reflects non-jurisdiction, not a clean bill.
• Non-SEC / product-safety-security — MATERIAL findings: This is the real Lens-10 story. In Aug 2024, security researchers (Dennis Giese, Braelynn Luedtke) demonstrated at DEF CON that DEEBOT X2 vacuums could be remotely hijacked — camera, microphone, and drive control — via a Bluetooth flaw exploitable from 100m+; a cloud vulnerability exposed ~7,000 devices. Documented real-world incidents: hacked units yelling racial slurs and chasing pets in Minnesota, LA, El Paso. Separately, Ecovacs faces privacy criticism for collecting user photos/video/audio to train AI, allegedly without clear consent. A South Korean regulator found the DEEBOT X8 Pro Omni lacked proper app authentication, exposing photos to third parties. Ecovacs promised an X2 security patch (Nov 2024) but independent verification of the fix has been limited. No monetary fine/consent-decree surfaced, but this is a live brand-trust, privacy-regulatory, and potential product-liability exposure — and for a camera-and-mic-in-your-home device sold into privacy-sensitive Western markets, it is the most important non-financial risk in the file.
• Item 3 (Legal Proceedings): n/a — no 10-K on the shelf; the disclosed litigation known from web is the Ecovacs⇄Dreame IP/non-compete suits.

Summary: No SEC/accounting-fraud findings (and none searchable via EDGAR). Material cybersecurity/privacy findings exist (DEF CON X2 hijack, 7,000-device cloud exposure, Korean regulatory finding, AI-training-data privacy criticism) — verified via web as of 2026-07-01; SEC EDGAR (LR/AAER) returned nil by non-jurisdiction. Full income-statement/balance-sheet forensics deferred to a hybrid refresh that ingests the audited annual report.

---

Phase D — Project & stress-test

Forward Projection

Bottom-up EPS for FY2026 / FY2027 / FY2028. Base = FY2025 actual: revenue RMB 19.04B, net profit RMB 1.76B, ~578.86M shares → EPS ~RMB 3.04; consistent with reported EPS(TTM) 2.93. All output lines with arithmetic; inputs.

Base case — revenue compounds low-teens (share held, price war persists but stable), margins roughly flat as opex discipline offsets pricing:

• FY2026 rev ~RMB 21.5B; net margin ~9.0% (vs ~9.2% FY2025) → net ~RMB 1.94B → EPS ~RMB 3.35.
• But Q1'26 printed profit −14.7% — so the FY2026 base carries real downside risk to this; a flat-to-down profit year is plausible if FX/price pressure persists.
• FY2027 rev ~RMB 24.0B; margin ~9.2% → net ~RMB 2.21B → EPS ~RMB 3.81.
• FY2028 rev ~RMB 26.6B; margin ~9.5% → net ~RMB 2.53B → EPS ~RMB 4.36.

Bull case — Tineco + GOAT mowers scale, overseas share stabilizes, price war eases, margin expands to ~11%: FY2028 rev ~RMB 30B, net ~RMB 3.3B, EPS ~RMB 5.7.

Bear case — Dreame/Roborock take more share, ASP erosion + FX keep compressing margin to ~6–7%, revenue growth slows to high-single-digits: FY2028 rev ~RMB 24B, net ~RMB 1.5–1.7B, EPS ~RMB 2.6–2.9 — i.e. no EPS growth over three years, the "growth curse" outcome.

Valuation cross-check. At ~58.92 CNY and base FY2026 EPS ~3.35, forward P/E ~17.6x — cheaper than the ~22x screen implies once you roll forward, if the base case holds. The bear EPS path (~2.7 in 2028) at any de-rating toward Roborock's ~19x = a stock in the low-50s CNY, i.e. downside to the 52-week low. Analyst avg target 83.08 CNY (+41%) embeds something closer to the bull path.

Forecast log (Lens 11 Brier tracker): skipped per --watchlist rule — no genuine committed base case in unattended breadth mode. If promoted to a thesis, log: 603486 FY2026 net profit >= RMB 1.9B, p≈0.45, resolves 2027-03-31.

Bull vs Bear

Bull case. Ecovacs is the #1 China brand and global #2 in a category still growing ~16% CAGR toward ~$28B by 2034; it has a real second growth leg in Tineco floor washers and a fast-emerging third in GOAT robotic lawn mowers (a higher-ASP, less-crowded category); it owns its LiDAR/battery/plastics supply (structural cost edge); it just proved it can restore ~20% ROE and ~50% gross margin through cost discipline; and at ~22x forward (~18x rolled) it's not demanding if mid-teens growth + stable margin hold. iRobot's death removes a Western incumbent and opens shelf space. Optionality: humanoid/commercial robotics via the Rockchip partnership.

Bear case (permanent-impairment risks). (1) It's losing the war it started. Roborock passed it globally (>23% vs ~14% intl share) growing 4x faster; Dreame expects to surpass its revenue. A category pioneer ceding share to two younger rivals simultaneously is the classic value-trap setup. (2) No moat against price. With no switching costs and copyable tech, the terminal state of this category may be structurally thin margins (see iRobot at 0.21x sales) — the ~50% gross margin is not obviously defensible when three funded rivals subsidize price. (3) Earnings have no visibility — profit fell 60% once, "recovered" 118%, then fell 15% again in the very next quarter; you cannot underwrite a multiple on a P&L this whippy.

Pre-mortem (18 months out, thesis broke): It's early 2028. Ecovacs held revenue but Dreame and Roborock kept subsidizing; Ecovacs matched to defend China share; gross margin slid back to ~44%, net margin to ~6%; FY2027 profit fell YoY; the "recovery" was revealed as a one-year FX/comp artifact; the stock re-rated to ~15x on RMB 2.6 EPS = ~40 CNY. Add a second privacy/security incident in Europe that triggers a regulatory sales restriction. That's the −30–40% path.

Are multiples too high? ~30x trailing on a share-loser: yes, on the trailing number. ~18x rolled on the base case: fair-to-cheap. The multiple is only justified if you believe the price war is easing — and Q1'26 says it isn't yet.

Contrarian view (what the market may be missing): Both ways. The bear contrarian: the Street's 83 CNY target and "buy" consensus under-weight that the terminal margin of a moat-less hardware category converges toward commodity — Ecovacs could be a structurally lower-margin business than 2025 suggests. The bull contrarian: the market is so fixated on the Roborock-is-winning narrative that it's mispricing Tineco + GOAT (the non-robot-vacuum ~55% of the business that is growing faster and competing in less-brutal categories) — if you value Ecovacs as "a floor-washer + lawn-mower company that also makes robot vacuums," the sum-of-parts is higher than the "losing robot-vac player" tape implies.

Devil's Advocate (short-seller)

Dismantling the bull case:

• Where revenue concentrates & the risk: ~50% in the robot-vacuum core — the single most price-competitive, moat-free consumer-electronics category on earth, with three funded Chinese rivals (Roborock public, Dreame + Narwal private with Tencent/other backing) all willing to subsidize price. Concentration isn't customer-level; it's category-level, and the category is a knife fight.
• Why the moat is weaker than bulls think: "15-year head start" means nothing when Dreame reached feature parity in ~3 years and now out-sells you. The LiDAR self-supply is nice but doesn't stop a rival from buying an equivalent module and undercutting on price. There is no lock-in.
• Most dangerous competitor bulls underestimate: Dreame — cross-town Suzhou rival, growing explosively, expanding into adjacent premium categories (even EVs/drones), and Ecovacs' own CEO is publicly rattled by it. It expects to pass Ecovacs on revenue and Roborock on profit.
• Worst capital-allocation moves: torching returns 2022–24 chasing overseas share (profit −60%), then still only recovering to the 2021 profit level four years later — value destroyed and not yet re-created.
• Assumptions that must hold for today's price: mid-teens revenue growth and stable/expanding margins simultaneously — the exact combination the sector has repeatedly failed to deliver ("revenue up, profit not").
• If growth disappoints 20–30%: on the bear EPS path (~RMB 2.6–2.9, flat 3-yr) with a de-rate to ~15x → ~40 CNY, ~−30% from ~59.
• Single scenario that permanently impairs: the category matures into a commodity (iRobot precedent) before Ecovacs establishes a durable premium/ecosystem — terminal gross margin resets from ~50% toward ~35%, and no amount of unit growth fixes it. Plausibility: moderate-and-rising, given three rivals in a permanent price war and zero switching costs. A privacy/security-driven Western sales restriction is a lower-probability but real tail.

Management Questions (ordered by information value)

1. Roborock now leads global share growing ~4x faster than you — what is your concrete plan and timeline to stop overseas share loss, and what unit-economics are you willing to accept to do it?
2. Q1 2026 profit fell 14.7% on rising revenue — is the FY2025 margin recovery structural, or was it an FX/non-recurring/comp artifact? Show us the bridge.
3. What is your terminal gross-margin assumption for the core robot-vacuum category given three funded rivals subsidizing price — and what stops it converging toward iRobot's outcome?
4. Selling expense is ~30% of revenue. Where does that ratio settle at maturity, and what's the plan if a price war forces it higher?
5. What is Dreame doing that genuinely worries you, beyond the "copycat" framing — and where are they actually ahead?
6. How much of your ~50% gross margin is attributable to in-house LiDAR/battery/plastics, and how durable is that cost edge as rivals scale their own sourcing?
7. Tineco and GOAT are your faster-growing, less-crowded legs — what share of group profit do you expect them to contribute in 3 years, and are you willing to be defined as a "cleaning appliance + lawn-robot" company rather than a robot-vacuum one?
8. On the 2024 DEF CON hijack and Korean authentication findings — what independently verifiable changes were made, and what is your standing liability/regulatory exposure in the EU/US on device privacy?
9. Your AI features rely on collecting in-home images/audio. How do you reconcile that data pipeline with tightening EU/US privacy regimes, and could a regulator restrict sales?
10. US tariffs forced 45% price cuts to "pass savings" — what is the real margin impact of the US tariff regime, and is the US market still profitable for you?
11. Capital allocation: dividend is a token ~0.5%. At what point do you return capital vs. keep reinvesting into a price war with diminishing returns?
12. Founder-to-second-generation transition: how is decision-making split between Chairman Qian Dongqi and CEO Qian Cheng, and what's the succession/governance depth below the family?
13. Inventory write-downs hit you in 2022–23 — what's changed in demand forecasting and channel inventory management to prevent a repeat in a slowing-China-consumer environment?
14. What is the realistic revenue timeline and TAM for the humanoid/commercial-robotics optionality (the Rockchip partnership), and how much R&D are you committing to it?
15. If you could only defend one of {China #1 position, overseas growth, gross margin} over the next three years, which do you sacrifice — and why?

---